Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Prostatic Neoplasms 28Neoplasm Metastasis 6Recurrence 5Breast Neoplasms 4Stomach Neoplasms 3Prostate Cancer Metastatic 3Neoplastic Cells, Circulating 3Carcinoma, Transitional Cell 3Carcinoma, Non-Small-Cell Lung 3Ovarian Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms, Castration-Resistant 1Prostate Cancer, Hereditary, 7 1Penile Neoplasms 1Nonseminomatous germ cell tumor 1Metastatic Castration-resistant Prostate Cancer, MCRPC 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Breast Cancer With Intracranial Metastases 1Lung Neoplasms 1Liposarcoma 1Hormone-Resistant Prostate Cancer 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Diarrhea 1

Interventions

Oxaliplatin 166Capecitabine 112Fluorouracil 95Docetaxel 85Cisplatin 84S 1 (combination) 83Leucovorin 64Paclitaxel 58Irinotecan 56pembrolizumab 36sintilimab 34Trastuzumab 34apatinib 30Bevacizumab 21Surgical Procedures, Operative 19Radiotherapy 19titanium silicide 17camrelizumab 17Nivolumab 17Ramucirumab 16Drug Therapy 15Hyperthermic Intraperitoneal Chemotherapy 14Folfox protocol 14Epirubicin 14tislelizumab 13Neoadjuvant Therapy 12Cetuximab 12XELOX 10Tegafur 10Carboplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Stomach Neoplasms × cabazitaxel × Clear all
NCT01365130 2019-04-12

Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen

Brown University

Phase 2 Terminated
15 enrolled 8 charts
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT01956149 2018-04-18

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed
65 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01757171 2018-04-03

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

Weill Medical College of Cornell University

Phase 2 Completed
85 enrolled 11 charts
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡